Intensity Therapeutics, Inc.
INTS
$1.85
-$0.01-0.54%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -54.37% | -83.17% | -81.14% | -110.80% | -38.99% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -100.00% | -100.00% | 1,023.08% | -- |
| Total Other Non-Cash Items | -17.28% | -33.30% | -34.41% | 207.24% | 182.42% |
| Change in Net Operating Assets | -231.91% | 101.83% | -464.11% | -871.92% | -183.63% |
| Cash from Operations | -111.24% | -71.01% | -285.39% | -118.02% | -31.55% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 205.50% | 203.74% | -- | -- | -- |
| Cash from Investing | 205.50% | 203.74% | -- | -- | -- |
| Total Debt Issued | -- | -100.52% | -100.52% | -98.98% | -89.78% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -84.19% | -97.75% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 70.76% | 96.33% | -600.36% | -16,281.16% | -- |
| Cash from Financing | -85.83% | -98.19% | 826.78% | 721.25% | 809.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -182.36% | -165.23% | 295.78% | 382.11% | 324.48% |